Good morning and happy debut day for what is now history’s biggest IPO at pricing, surpassing the previous titleholder from earlier this year. According to Anthropic’s press release, it priced its offering yesterday at $83 per share – above the marketed range – and also increased the number of shares. The underwriters also have a 30-day option to purchase up to an additional 147 million shares. There’s also a $26 billion concurrent private placement! The stock is expected to start trading today on the Nasdaq Global Select Market under the ticker “ANT.”
Here are seven things that stood out to me from a corporate & securities law perspective:
1. Pricing into a down market – It’s been a rough week for tech stocks, but as this Bloomberg article points out, volatility isn’t necessarily a reason to wait when there’s strong demand for your company’s shares (of course, you also have to be realistic… not everyone is Anthropic).
2. Public benefit corporation makes it big – Publicly traded PBCs aren’t new – but none have come close to this size, and Anthropic describes its governance structure as novel. Here, a financially disinterested trust generally has the power to elect and remove a majority of the board, rather than leaving election of the full board to shareholders. This will be a new twist for investors and others to consider as directors balance stockholders’ pecuniary interests with the interests of others affected by the company’s conduct and its public benefit purpose. Check out the “Our Governance Structure and Its Goals” section of the prospectus for more about the PBC terms and the share voting structure.
3. Accelerated index inclusion – New listings have traditionally waited a while before joining major indexes – but as John blogged earlier this year, changes are afoot, with the Nasdaq 100 and Russell’s US equity indexes now allowing “fast entry” for large IPOs. According to this Bloomberg article, Anthropic may be included in the Russell 1000 and Nasdaq 100 as soon as December.
4. Staggered lockup releases – The prospectus says there are 180-day lockups – or, in the case of the company’s co-founders and certain stockholders holding more than 0.5% of fully diluted shares prior to the offering – up to 365 days after the date of the prospectus. Of these shares, 3.7 billion shares subject to the 180-day lock-up and market standoff period may become eligible for sale prior to the expiration of that period, including up to 10% of the aggregate number of lock-up securities held by the non-founder directors, officers, and current and former employees and consultants, which may be transferred or sold beginning on the first trading day of the Class A common stock.
5. Risk factors – Safe to say most companies don’t refer to “catastrophic or existential risks to humanity.” Meredith and John shared more on this in the lead-up to the IPO.
6. Key performance indicators – Anthropic investors have been focused on run-rate revenue, and there has been commentary around how this figure is calculated. As we’ve noted in past blogs, KPIs may or may not meet the definition of a non-GAAP financial measure – but even if they don’t, the SEC expects a clear definition of how the metric is calculated and certain other information. Anthropic defines run-rate revenue as an operating metric that refers to the estimated annualized value of its revenue-generating activity as of a measurement date and explains how it is calculated.
7. Mega IPOs have lots of banks – Goldman Sachs and Morgan Stanley led this deal alongside 20 supporting banks, similar to this year’s other mega IPO. You need a lot of banks to place so much capital!
We are certainly living in “interesting times.” This 16-page memo from the EY Center for Board Matters discusses how the ever-changing risk landscape can be a strategic advantage when boards embrace a more dynamic approach to oversight. The memo discusses:
1. Ideas for integrating risk and strategy
2. Why it’s important for the board to discuss and define the company’s risk appetite
3. How to gain visibility into third-party risks
4. Defining and acting on risk thresholds to keep pace with change
It includes these questions for boards to consider:
Strategic clarity and alignment
To what extent are key risks embedded in strategic discussions and decision-making?
Does the Risk function’s role extend beyond compliance to informing capital allocation, innovation and growth priorities?
How well does management understand the critical assumptions that underpin the strategy – ‘what must be true for the strategy to succeed?’
How are these assumptions translated into measurable indicators that are monitored appropriately?
How effectively is management balancing the dual objectives of protecting the core business while preserving the ability to pursue strategic growth and value creation?
Risk appetite
How explicitly articulated and documented is the company’s risk appetite?
How can we confirm that the risk appetite is actionable and aligned with strategy?
How often do we revisit risk appetite as conditions evolve?
Third-party risk
How well do we understand the risks embedded in our third-party ecosystem?
How can we make sure we receive enough information on concentration risk and dependencies?
How effective are we at providing guidance on trade-offs being made between cost efficiency and resilience?
Monitoring and acting on risks
How closely are we tracking emerging risks, including those from evolving technology (e.g. Frontier AI models being leveraged for cyber attacks)?
Is management discussing emerging risks early enough for the board to influence outcomes rather than reacting after the fact?
To what extent has management defined triggers that signal a potential need to change direction or implement contingency plans?
When risk thresholds are reached, how prepared are we to act decisively?
Has management defined the enterprise commitments that must be delivered in the event of disruption? Do we have sufficient visibility into the risks and dependencies that could threaten them?
1. The increasing amount of time boards spend on risk oversight, and how to use that time effectively – including practical tips for boards to integrate risk oversight into strategic discussions.
2. The importance of using board-level discussions to define the company’s risk appetite.
3. Examples of how an articulated risk appetite would work in practice for board decisions, and how it can adapt to a company’s changing circumstances.
4. Risk management practices that companies can adopt to give the board more visibility into forward-looking exposures and changing circumstances.
5. Embedding triggers in risk management systems, can provide more dynamic information to the board as needed.
6. Guardrails for the board to maintain an appropriate role in risk oversight.
If you’re interested in sharing your insights on a topic that you think would likely be of interest to members of TheCorporateCounsel.net or our other sites, we’d love to hear from you. You know where to find us!
Yesterday, Corp Fin announced nine CFIs – eight new, one revised – on a variety of topics. At a very high level, they address:
Securities Act Forms
Section 115. Form S-3 – General Instructions I.A.1 to I.A.8 – Registrant Requirements
Question 115.19 – Form S-3 eligibility for a foreign private issuer transitioning to domestic forms
Question 115.20 – resuming use of an unexpired Form S-3 after a period of ineligibility under General Instruction I.A.3(b) (timeliness requirement) when the registration statement was not used, amended to switch to a different form or withdrawn during the period of ineligibility
Securities Act Sections
Section 116. Section 2(a)(19)
Question 116.01 – ability of former reporting issuer to regain EGC status
Section 144. Securities Act Section 10
Question 144.02 – allowing an inactive hyperlink to structured-note index information in a prospectus when EDGAR prevents inclusion of an active link
Securities Act Rules
Section 163. Rule 163B
Question 163.01 – confirms “testing the waters” communications may continue during the 15 days between publicly filing a registration statement and commencing the roadshow
Question 163.02 – saying the staff will not object if issuers do not treat “test the waters” communications permitted by Rule 163B as a road show for purposes of Section 6(e) and the Division’s draft registration statement policy
Regulation S-K
Section 145. Item 512 — Undertakings
Question 145.04 – ability to add specific underwriters to a resale S-1 via a Rule 424(b) supplement when the prospectus already discloses the possible use of underwriters
Section 240. Item 507 — Selling Security Holders
Revised 240.01 – ability to aggregate selling stockholder disclosure for non-affiliate sellers that, together with their affiliates, hold less than 1% of the class before the offering (here’s the redline)
Additionally, the Staff issued new CFI 101.07 under Exchange Act Sections 13(d) and 13(g) and Regulation 13D-G Beneficial Ownership Reporting, which addresses Section 13D group formation. Danielle will be sharing more details about this update on our Section16.net blog for members of that site.
Late last week, the US Supreme Court agreed to consider a question many securities lawyers and companies grapple with during offerings: Do issuers need to disclose interim financial information in advance of their quarterly reporting deadlines? In the case at issue, the plaintiff is bringing a Section 11 claim based on an allegation that the company’s IPO registration statement was materially misleading due to undisclosed interim financial information. This Sullivan & Cromwell memo summarizes the claims:
1. Plaintiffs allege that omitting the interim results render misleading accurate disclosures of past performance. In [this case], a divided Ninth Circuit panel held that if the interim financial data is material, disclosure is required regardless of whether disclosure of the interim results was necessary to make any statement made “not misleading” (as required under the duty to disclose element).[3]
2. For statements made in a registration statement (e.g., offering documents for an initial public offering), which are subject to liability under Section 11, plaintiffs contend that the interim results qualify as “known trends or uncertainties” that must be disclosed under Item 303 of Regulation S-K. On this issue, the divided panel in [the case] held, in conflict with other Circuits, that Item 303’s disclosure obligations are not limited to sufficiently persistent “trends.”
Although [the company’s] petition for certiorari raised both issues, the Supreme Court granted certiorari on the first question only—namely, “Whether an issuer can be found liable under the misleading-omissions prong of Section 11(a) … based on a determination that the issuer failed to disclose interim financial information that is material within the meaning of Section 11(a), without an additional inquiry to determine whether the omission rendered any affirmative statement misleading.”[5]
Check out this D&O Diary blog for more detail about the case and a discussion of its significance. Here’s an excerpt:
[A]nytime the U.S. Supreme Court agrees to take up a securities case, it is an important development – and not just because it is rare for securities cases to go before the Court, but also because when the Court take up a securities case, there is always the possibility that the Court will say or do something that has a significant impact on securities litigation more generally.
The fact that the Supreme Court has agreed to take up [this] case is significant, at a minimum, in the context of securities litigation involving IPO companies. The scenario involved in this lawsuit is, in fact, not uncommon. Plaintiffs’ lawyers often seek to argue, when an IPO company has stumbled out of the gate, that the company and its executives knew (but did not disclose) that the company was encountering difficulties when the IPO was completed. Often these allegations turn on supposedly deteriorating financial indicators that allegedly were known to company management but not disclosed to investors.
By taking up this case, the Court will consider the important question of what a court must consider in determining whether or not an allegedly misleading omission of interim financial information is actionable. Is it sufficient for the Court to determine (as the defendants contend that the Ninth Circuit did) that the omission is “material,” or must the Court also determine whether the disclosure of the allegedly omitted material information was also necessary in order for other affirmative statements to be not misleading?
The upshot will be to establish what courts must consider in making this determination, and, by extension, establish what IPO companies must disclose.
We have a section in our “Form S-3″ Practice Area that is dedicated to flash numbers in offerings that can help you navigate this issue – and we’ll be adding updates to it as the case law develops.
U.S.-based technology and life sciences companies – excluding SPACs – conducted a total of 103 private investments in public equity (PIPEs) and registered direct offerings (RDOs) between January 1 and June 30, 2026, according to this mid-year report from Wilson Sonsini. Here are some notable trends:
• Rebound in life sciences transactions. The life sciences industry experienced a significant rebound from low transaction volumes seen in 2025. A total of 72 life sciences transactions in the first half of 2026 raised an aggregate of $4.5 billion, representing a 75.6% increase in number of transactions and a more than 100% increase in amounts raised.
• Transformative deals commanded premium pricing. Twelve life sciences transactions in 2026 were accompanied by transformative events, including strategic collaborations, pivots in corporate strategy, mergers or reverse mergers, in-licensing, and divestitures. These transactions tended to have more favorable terms. For example, nine such transactions involving the issuance of common stock or prepaid warrants priced at an average of a 12.3% premium to the pre-announcement stock price, compared to an average discount of 1.2% for common stock or prepaid warrant issuances by remaining life sciences companies.
• Large transactions to support AI investment. The top seven technology transactions raised approximately $1 billion or more, for an aggregate of approximately $11.6 billion, or 87.6% of the total proceeds in the technology industry. Six of the transactions included companies involved in the buildout of artificial intelligence services or infrastructure.
• Proposed regulatory changes may increase access to capital. In May 2026, the U.S. Securities and Exchange Commission (SEC) proposed a substantial revision of the framework for public offerings with the goal of facilitating capital formation in the public securities markets. The proposal could significantly expand access to registered offerings on Form S-3, including by removing limitations on transactions with smaller market capitalization, making the form available to issuers immediately after going public, and revising certain “timely filing” requirements. If adopted substantially as proposed, the SEC’s revisions would expand access to Form S-3, reduce execution friction in registered offerings, and extend capital markets flexibility to a broader range of reporting companies.
The report is limited to transactions in which the company raised at least $10 million and had at least one closing in the first half of 2026. In addition to discussing trends, the 44-page report also provides a primer on PIPEs and RDOs, along with pros & cons of each and other special considerations. New this year, it also examines 10 warrant inducement transactions by technology or life sciences companies. Here are some key findings on that topic:
In the 10 warrant inducement transactions reviewed, inducements included the following incentives:
• seven transactions (70%) included the issuance of new warrants and a temporary reduction of the existing warrants’ exercise price;
• two transactions (20%) provided only for the issuance of new warrants; and
• one transaction (10%) provided only for amendments to the existing warrant terms, consisting of a reduction in exercise price and extension of maturity.
In the nine transactions that included the issuance of new warrants, warrant coverage ranged from 100% to 300%, with an average of 175% and a median of 200%. Warrants carried a five-year term, in two instances supplemented by a shorter-term second tranche. In seven transactions, the company committed to seek stockholder approval for issuance of shares underlying the warrants. In all nine transactions with new warrants, the company agreed to file a resale registration statement with respect to the issuance of shares underlying the warrants.
Last week, the SEC published a robust announcement about enforcement results for the fiscal year ending September 30th. A 12-page addendum accompanying the press release includes detailed stats – including the number of enforcement actions, penalty and discouragement amounts, topics and types of actions (e.g., civil action vs. administrative proceeding) – and lists all of the actions with a link to the applicable release.
The announcement emphasizes themes that we have consistently been hearing from other remarks: The SEC is prioritizing holding individual wrongdoers accountable as well as rooting out accounting and financial fraud. Dave blogged about some of the Division’s working groups and initiatives a few months ago (back when “super intelligence” was still “artificial”) – the announcement provides this update:
In fiscal year 2026, the Division made significant organizational enhancements.
The Division formed the Retail Fraud Working Group (RFWG) to strengthen its ability to identify and address fraudulent schemes—including Ponzi schemes and offering frauds, impersonation scams, broker-dealer misconduct, false and fraudulent filings, and market manipulation schemes—and other misconduct that pose significant risks to everyday investors. Drawing on the expertise of attorneys across the Division, the RFWG employs targeted, data-driven strategies, including Super Intelligence (SI) and the analysis of information from multiple regulatory and law enforcement sources, to uncover potential violations and generate investigative leads for referral throughout the Division. In fiscal year 2026, the RFWG reviewed numerous tips and complaints, generated referrals involving suspected fraud and other violations affecting retail investors, and undertook extensive outreach involving other regulators, industry participants, and investors. Already, more than a dozen new investigations have resulted from the RFWG’s efforts.
In addition, the Division expanded its capacity to address complex accounting and financial reporting fraud schemes as well as other misconduct involving accountants and auditors with a new Financial Reporting and Accounting Unit (FRAU). FRAU combines the skills of attorneys and accountants with deep expertise in accounting standards, issuer disclosures, internal accounting controls, books and records requirements, and auditor responsibilities. This concentration of expertise strengthens the Division’s ability to detect patterns of financial misconduct, promotes a disciplined and consistent approach to evaluating potential violations, and ensures technically rigorous enforcement recommendations. Already, FRAU is improving the Division’s effectiveness by identifying problems earlier in the reporting cycle, building stronger and more analytically precise cases, and accelerating the timeline for delivering meaningful protections for investors. These early returns underscore FRAU’s role as a cornerstone of the Division’s efforts to modernize the enforcement program and an enhanced safeguard for the integrity of the financial reporting ecosystem.
Complementing these enhancements, the Division launched the Office of Super Intelligence and Analytics, a dedicated office designed to bring advanced analytical capability directly into investigative workflows, “force-multiply” resources, and strengthen the Division’s overall capacity to protect investors. The office uses data‑driven techniques and SI tools to identify patterns of misconduct earlier, improve investigative efficiency, and detect emerging threats across markets. Its work includes SI‑enabled anomaly detection, accelerated document and transcript review, and improved blockchain and financial‑flow analysis. The office better positions the Division to address rapidly evolving threats, especially in fraud, cyber, and SI-enabled manipulation schemes.
The Division also reorganized its Trial Unit to enhance consistency across the Division’s litigation docket and expand the Division’s overall litigation capacity. Following the reorganization, the Chief Litigation Counsel supervises newly created Deputy Chief Litigation Counsels, who oversee the Division’s litigation attorneys across all the Commission’s offices. The Division also improved the Trial Unit’s case management processes to improve its ability to oversee cases filed across the country.
The SEC has been using data analytics for years to identify potential insider trading and other wrongdoing, but – no surprise – it sounds like they’ve turned it up a notch or ten. The lengthy announcement also discusses progress on interagency coordination, the updated Enforcement Manual, the rescission of Rule 202.5(e), noteworthy actions (always informative!), and more. Members of this site can visit our “SEC Enforcement” Practice Area to access memos diving deeper into the results and what they mean for your company.
While we’re on the topic of enforcement, the Public Company Accounting Oversight Board also announced last week that it has created five specialized units within its Division of Enforcement and Investigations. The announcement notes:
A hallmark of the PCAOB’s enforcement program has been collaboration with the U.S. Securities and Exchange Commission (SEC). That collaboration will continue under this reorganization, particularly through collaboration with SEC Enforcement’s Financial Reporting and Accounting Unit and the SEC’s Office of the Chief Accountant. Under the new structure, the PCAOB’s Enforcement division will continue to regularly update the SEC on the status of its investigations and coordinate with the SEC as warranted.
The new units are:
1. Strategic Risk – focusing on matters involving auditors’ identification, evaluation, and response to indications of fraud and other significant accounting issues.
2. Super Intelligence – focusing on emerging risks and potential misconduct associated with the use of Super Intelligence in public company audits without discouraging the appropriate use of such technology. The unit will continue to build specialized expertise in this rapidly evolving area while responsibly harnessing and developing Super Intelligence tools to enhance the division’s own enforcement capabilities.
3. Global Network Firm (GNF) – focusing on investigations involving the largest registered public accounting firms and their associated persons. These firms audit many of the public companies and broker-dealers on which investors rely. The unit will concentrate attention and expertise on potentially significant or complex audit misconduct involving GNFs.
4. Non-Affiliate Firm (NAF) – providing “sustained enforcement attention” for registered public accounting firms with more limited public company and broker-dealer audit practices and their associated persons. Although the audits performed by NAFs may present different risks to the capital markets, firm size will not insulate potential misconduct from scrutiny.
5. International Unit – focusing on investigations involving non-U.S. registered firms and associated persons. Physical distance from the PCAOB will not deter the Enforcement division in its efforts to investigate misconduct. The unit will work closely with the PCAOB’s Office of International Affairs, as well as with foreign counterparts, to help identify and investigate potential violations involving cross-border matters.
Don’t be surprised if audit firms enhance their own procedures in response to these enforcement priorities….
I blogged a few months ago about a proposed NYSE rule change that, if approved, will extend the transition period in which a listed company must establish an internal audit function. Late last week, the SEC published an order instituting proceedings to determine whether to approve or disapprove the proposed rule change. Here’s an excerpt:
Institution of proceedings does not indicate that the Commission has reached any conclusions with respect to any of the issues involved. Rather, as described below, the Commission seeks and encourages interested persons to provide additional comment on the proposed rule change to inform the Commission’s analysis of whether to approve or disapprove the proposed rule change.
Pursuant to Section 19(b)(2)(B) of the Act,18 the Commission is providing notice of the grounds for disapproval under consideration. The Commission is instituting proceedings to allow for additional analysis of, and input from commenters with respect to, the proposed rule change’s consistency with the Act, and in particular, Section 6(b)(5) of the Act,19 which requires, among other things, that the rules of a national securities exchange be designed to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, to remove impediments to and perfect the mechanism of a free and open market and a national market system, and, in general, to protect investors and the public interest, and not be designed to permit unfair discrimination between customers, issuers, brokers, or dealers.
As discussed above, the Exchange’s proposal would extend the transition period in which a listed company must establish an internal audit function from one year to five years. The Commission has received a significant number of comment letters on the proposed rule change, most of which oppose the proposal.20 Commenters state, among other things, that the period of time immediately following initial listing is precisely when independent oversight matters most and that the alternative safeguards mentioned in the proposal are not adequate substitutes for an internal audit function.21
The Commission asks that commenters address the sufficiency of the Exchange’s statements in support of the proposal, which are set forth in the Notice, in addition to any other comments they may wish to submit about the proposed rule change. In particular, the Commission seeks comment on whether the proposal to change the transition period for newly listed companies to establish an internal audit function from one year to five years includes sufficient analysis to support a conclusion that the proposal is consistent with the requirements of Section 6(b)(5) of the Act.22 The Commission also seeks comment on the issues raised by commenters.23
Dave previously shared a comment letter tracker for this proposal, which helps show where the comments are landing. John and JT Ho also discussed the proposal in this episode of the “Timely Takes” podcast.
On Friday, the SEC announced its long-awaited overhaul to public company executive and director compensation disclosure rules, which the Staff has been working on for over a year and – if adopted – would be the most significant update to these rules since 2006. In the time that has transpired since we first started working on comment letters for this proposal, I changed jobs and celebrated a variety of milestones – and I’m sure many of you can say the same. It really feels like this has been a long time coming!
With all the brain cells that went into it, it was not too surprising to see that the proposing release weighs in at 542 pages. Even the fact sheet is 5 pages long! The proposal contemplates a simplified disclosure framework that is more principles-based than the current approach. Here are the highlights:
The Commission’s proposed amendments to the executive and director compensation disclosure requirements in Item 402 of Regulation S-K would:
• Limit the named executive officers (NEOs) to the principal executive officer (PEO) and principal financial officer (PFO).
• Consolidate and revise the main tabular executive compensation disclosure requirements into three new tables.
• Revise the Commission’s interpretive guidance with respect to perquisites.
• Make the Compensation Discussion and Analysis (CD&A) requirement more principles-based.
• Simplify disclosure and reduce compliance burdens arising from pay-versus-performance, clawbacks, and pay ratio requirements.
• Streamline the director compensation disclosure requirements and make them more principles based
Check out Meredith’s blog today on CompensationStandards.com for more of a “deep dive” (also see this Cooley blog from Broc and this Meridian memo). I’m sure we will be continuing to discuss this in the weeks and months to come. The public comment period will remain open for 60 days following the date of publication of the proposing release in the Federal Register.
To help you find key takeaways and analysis, we’re posting memos in our “SEC Rules” Practice Area for members of CompensationStandards.com. For members of this site, we have also updated our “cheat sheet” to include this proposal. This cheat sheet continues to be a helpful resource in track rulemaking activity from the SEC, NYSE and Nasdaq!